The effect of dydrogesterone in prevention of preeclampsia in high-risk pregnancy of primigravidae women that has been referred to gynecology clinic
Not Applicable
Recruiting
- Conditions
- Pregnancy, childbirth and the puerperium.Pregnancy, childbirth and the puerperiumO00-O99
- Registration Number
- IRCT20151228025732N30
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 168
Inclusion Criteria
Women that have aged 18 to 40 years
Nulliparous Women
The body mass index is equal to or greater than 30 kg / m2
Exclusion Criteria
The history of consumption of progesterone supplements in the last 6 months
Contraindications for the use of progesterone
Use of drugs that induce liver enzymes activation (carbamazepine, phenytoin and rifampin)
Diagnosis of embryonic anomalies by ultrasound
Previous cases of systemic diseases, such as asthma, diabetes, liver and kidney disorders, cardiovascular disease, connective tissue diseases.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal bleeding. Timepoint: During pregnancy and after childbirth. Method of measurement: Examination.
- Secondary Outcome Measures
Name Time Method